Company: NIVFW
Filing Date: 2025-10-10
Form Type: F-1/A
Source: 0001213900-25-098135
Chunk: 211

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-10
Form: F-1/A
Chunk 211
---
,852and 50,747ordinary shares with par value of $ Nil. The number of shares as above have taken into consideration the reverse stock splits effected on February 11, 2025 at an exchange ratio of one (1) share for twenty (20) shares and on May 5, 2025 at an exchange ratio of one (1) share for ten (10) shares. Pursuant to ASC 505 the reverse stock split has been applied retrospectively. F-24

Additional paid-in capital

| Balance as at January 1,2023                                                           |     | $ |  1,464,959 |   |
| Issuance of shares as compensation for services (Note 1)                               |     |   |  2,866,856 |   |
| Balance as at December 31, 2023                                                        |     |   |  4,331,815 |   |
| Issuance of shares through Equity Line of Credit (Note 2)                              |     |   |  1,936,236 |   |
| Issuance of shares through conversion of convertible notes                             |     |   |  2,650,000 |   |
| Decrease in subscription receivable due to reduction of work by professionals (Note 1) |     |   | (2,766,856 | ) |
| Business Combination (Note 3)                                                          |     |   | (6,028,690 | ) |
| Balance as at December 31, 2024                                                        |     | $ |    122,505 |   |

| * | - the number of shares below have been amended to apply the two reverse stock splits in February 2025 and in May 2025 retrospectively. |

Note 1:

Note 2: On November 21, 2024, the Company
entered into a Common Shares Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC (“White
Lion”) and a related Registration Rights Agreement (the “RRA”). Pursuant to the White Lion Purchase Agreement, the Company
has the right, but not the obligation, to require White Lion to purchase, within 36 months from the Agreement effective date up to One
Hundred Million Dollars ($) in aggregate gross purchase price of newly issued Ordinary Shares, with an automatic increase to
Three Hundred Million Dollars ($) upon any substantial M&A or Material Transaction (as defined in the White Lion Purchase
Agreement) and